rrd106034_118989.html

-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, RQcHdtUi9wzOfKVx+JuggKh3BQVZvauRJgYoGk3RqkEfzBeqq0mBcUJf60xNqVaG f19hlqIydmUCn7j/6ncdLQ== 0001181431-06-036477.txt : 20060612 0001181431-06-036477.hdr.sgml : 20060612 20060612202419 ACCESSION NUMBER: 0001181431-06-036477 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20060608 FILED AS OF DATE: 20060612 DATE AS OF CHANGE: 20060612 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: RIEDEL NORBERT G CENTRAL INDEX KEY: 0001161662 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-10824 FILM NUMBER: 06901090 BUSINESS ADDRESS: BUSINESS PHONE: 8479483980 MAIL ADDRESS: STREET 1: BAXTER INTERNATIONAL INC STREET 2: ONE BAXTER PKWY DF2-2W CITY: DEERFIELD STATE: IL ZIP: 60015 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: OSCIENT PHARMACEUTICALS CORP CENTRAL INDEX KEY: 0000356830 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 042297484 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1000 WINTER STREET STREET 2: SUITE 2200 CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 7813982300 MAIL ADDRESS: STREET 1: 1000 WINTER STREET STREET 2: SUITE 2200 CITY: WALTHAM STATE: MA ZIP: 02451 FORMER COMPANY: FORMER CONFORMED NAME: GENOME THERAPEUTICS CORP DATE OF NAME CHANGE: 19941215 FORMER COMPANY: FORMER CONFORMED NAME: COLLABORATIVE RESEARCH INC DATE OF NAME CHANGE: 19920703 4 1 rrd121226.xml FORM 4 X0202 4 2006-06-08 0 0000356830 OSCIENT PHARMACEUTICALS CORP OSCI 0001161662 RIEDEL NORBERT G 1000 WINTER ST. SUITE 2200 WALTHAM MA 02451 1 0 0 0 Common Stock 2006-06-08 4 A 0 2400 0 A 5919 D Stock Options (right to buy) 1.19 2006-06-08 4 A 0 6000 0 A 2016-06-07 Common Stock 6000 6000 D Restricted Shares issued under the Company's 2001 Incentive Plan and will vest in equal annual installments over two years. Stock Options issued under the Company's 2001 Incentive Plan and will vest in equal annual installments over three years. Jospeh D. Vittiglio, Esq., Senior Corporate Attorney - Power of Attorney 2006-06-12 EX-24. 2 rrd106034_118989.htm POWER OF ATTORNEY rrd106034_118989.html

					POWER OF ATTORNEY



      I hereby constitute and appoint each of Robert E. Farrell, Jr. and Joseph Vittiglio, Esq.,
signing singly, my true and lawful attorney-in-fact to:

(1)	execute for and on my behalf, in my capacity as a director of Oscient
Pharmaceuticals Corporation (the "Company"), Forms 3, 4 and 5 in accordance
with Section 16(a) of the Securities Exchange Act of 1934 and the rules
thereunder;

(2)	do and perform any and all acts for and on my behalf that may be necessary or
desirable to complete and execute any such Form 3, 4 or 5 and timely file such
form with the United States Securities and Exchange Commission and any stock
exchange or similar authority; and

(3)	take any other action of any type whatsoever in connection with the foregoing
which, in the opinion of such attorney-in-fact, may be to my benefit, in my best
interest, or that I am legally required to do, it being understood that the documents
executed by such attorney-in-fact's discretion.

      I hereby grant to each such attorney-in-fact full power and authority to do and
perform any and every act and thing whatsoever requisite, necessary, or proper to be done
in the exercise of any of the rights and powers herein granted, as fully to all intents and
purposes as I might or could do if personally present, with full power of substitution or
revocation, hereby ratifying and confirming all that such attorney-in-fact, or such
attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue
of this power of attorney and the rights and powers herein granted.  I acknowledge that
the attorneys-in-fact, in serving in such capacity at my request, are not assuming, nor is
the Company assuming, any of my responsibilities to comply with Section 16 of the
Securities Exchange Act of 1934.

	This Power of Attorney shall remain in full force and effect until I am no longer
required to file Forms 3, 4 and 5 with respect to my holdings of and transactions in
Company securities, unless I earlier revoke it in a signed writing delivered to the
attorneys-in-fact.

	IN WITNESS WHEREOF, I have caused this Power of Attorney to be executed
as of this 23rd day of March 2006.



					_/S/__________________________________
					Norbert Riedel, Ph.D
      					Director, Oscient Pharmaceuticals Corporation

-----END PRIVACY-ENHANCED MESSAGE-----